Companies / BOC Sciences / Roledumab
BOC Sciences

Roledumab | BOC Sciences

Roledumab is a monoclonal antibody that targets RHD. Roledumab is undergoing clinical trials for the treatment of Rh disease.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.